iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 The outlook for obesity from 2026 to 2030 The world (biggest) obesity and
Description
*Body Pharm Retatrutide pen can be dosed to 8 mg by using the 8 mg marker on the dosage selector
The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.
Improved metabolic health
Headlines are running that millions more people should be taking statins
